San Antonio Breast Cancer Symposium: Press Releases - SABCS 2011

Home About SABCS 2011 Overview Patient Advocates Program Schedule Past Symposia FAQs Contact Us

SABCS

Search:

SABCS 2011 Resources Registration Housing Travel & Transportation Presenter Instructions Support & Exhibits Press Releases Media Event Photos

Media Contact:
Jeremy Moore
(215) 446-7109
Jeremy.Moore@aacr.org

In San Antonio:
(210) 582-7021

Press Releases > SABCS 2011

2011 CTRC-AACR San Antonio Breast Cancer Symposium to Focus
on New Treatments and Prevention
Brachytherapy Was Associated With Twofold Increased Risk for Mastectomy, Complications [12/6/2011 5:30 p.m.]
Diabetes and Obesity Increase Risk for Breast Cancer Development [12/6/2011 5:30 p.m.]
Molecular Differences May Be Used to Predict Early vs. Late Hormone Receptor-Positive Breast Cancer Recurrence [12/6/2011 5:30 p.m.]
New Test Predicts Risk for Recurrence for Patients With DCIS [12/6/2011 5:30 p.m.]
Zoledronic Acid Shows Long-Term Benefit in Survivorship for Premenopausal ER-Positive Breast Cancer [12/7/2011 9:30 a.m.]
Immediate Bisphosphonate Use With Endocrine Therapy Reduced Recurrence, Increased Survival in Postmenopausal Early Breast Cancer [12/7/2011 9:45 a.m.]
Institute of Medicine to Release Report on Breast Cancer and the Environment [12/7/2011 12:30 p.m.]
Clodronate Appeared Safe, Modestly Affected Breast Cancer Disease Events [12/7/2011 2:45 p.m.]
Oral Bisphosphonate Did Not Improve Prognosis for Patients With Breast Cancer [12/7/2011 3:00 p.m.]
Breast Cancer Mortality Higher in Hispanic Women [12/7/2011 5:00 p.m.]
Obesity Linked to Worse Outcomes in Early Breast Cancer Treatment [12/7/2011 5:00 p.m.]
Addition of Bevacizumab to Conventional Therapy Improved Progression-Free Survival in HER2-Positive Breast Cancer [12/7/2011 5:30 p.m.]
Dual HER2 Blockade Significantly Extends Progression-Free Survival [12/7/2011 5:30 p.m.]
Exemestane Plus Everolimus Increased Progression-Free Survival for Women With Metastatic Breast Cancer [12/7/2011 5:30 p.m.]
Addition of Trastuzumab May Potentially Equalize Disease-Free Survival Outcomes Among Obese and Normal-Weight Patients [12/8/2011 7:00 a.m.]
MRI May Be Noninvasive Method to Measure Breast Cancer Prognosis [12/8/2011 7:00 a.m.]
Bilateral Oophorectomy Associated With Higher Prevalence of Low Bone Mineral Density and Arthritis in YoungerWomen [12/8/2011 12:30 p.m.]
Many Women Do Not Undergo Breast Reconstruction After Mastectomy [12/8/2011 12:30 p.m.]
Risk for Developing New Cancer in Other Breast Increased for Survivors With BRCA Mutation [12/8/2011 12:30 p.m.]
Intermittent, Low-Carbohydrate Diets More Successful Than Standard Dieting, Present Possible Intervention for Breast Cancer Prevention [12/8/2011 5:00 p.m.]
Starch Intake May Influence Risk for Breast Cancer Recurrence [12/8/2011 5:00 p.m.]

Home | About SABCS | 2011 Overview | Patient Advocates | Program Schedule | Past Symposia | FAQs | Contact Us
Registration | Housing | Travel & Transportation | Presenter Instructions | Support & Exhibits | Press Releases | Media | Event Photos

Rich Markow, Director, Symposia
Cancer Therapy & Research Center at UT Health Science Center San Antonio

7979 Wurzbach Road, MC 8224 San Antonio, TX 78229 USA
Phone: 210-450-1550 Fax: 210-450-1560 Email: sabcs@uthscsa.edu

Copyright © 2012 SABCS. All rights reserved. - Privacy Policy